Myelofibrosis

Myelofibrosis is a chronic myeloproliferative neoplasm characterized by clonal stem cell proliferation, aberrant inflammatory cytokine production, and progressive replacement of normal hematopoietic bone marrow with reactive fibrous tissue

Myelofibrosis is a chronic myeloproliferative neoplasm characterized by clonal stem cell proliferation, aberrant inflammatory cytokine production, and progressive replacement of normal hematopoietic bone marrow with reactive fibrous tissue

Myelofibrosis is a chronic myeloproliferative neoplasm characterized by clonal stem cell proliferation, aberrant inflammatory cytokine production, and progressive replacement of normal hematopoietic bone marrow with reactive fibrous tissue

Primarily affecting the hematologic system in older adults, the condition arises either as primary myelofibrosis or secondarily following polycythemia vera or essential thrombocythemia Patients frequently experience debilitating systemic symptoms, including severe fatigue, night sweats, cachexia, and fever, alongside an increased risk of leukemic transformation and thrombohemorrhagic complications

Primarily affecting the hematologic system in older adults, the condition arises either as primary myelofibrosis or secondarily following polycythemia vera or essential thrombocythemia

Disruption of normal medullary blood cell production leads to cytopenias—predominantly worsening anemia and thrombocytopenia—as well as extramedullary hematopoiesis that commonly causes severe splenomegaly and hepatomegaly Patients frequently experience debilitating systemic symptoms, including severe fatigue, night sweats, cachexia, and fever, alongside an increased risk of leukemic transformation and thrombohemorrhagic complications

Disruption of normal medullary blood cell production leads to cytopenias—predominantly worsening anemia and thrombocytopenia—as well as extramedullary hematopoiesis that commonly causes severe splenomegaly and hepatomegaly